List of Tables
Table 1. Global Diabetes Medicines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Diabetes Medicines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Diabetes Medicines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Diabetes Medicines Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Diabetes Medicines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Diabetes Medicines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Diabetes Medicines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Diabetes Medicines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Diabetes Medicines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Diabetes Medicines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Diabetes Medicines, Product Types and Applications
Table 12. Global Key Manufacturers of Diabetes Medicines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diabetes Medicines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Diabetes Medicines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diabetes Medicines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Diabetes Medicines Sales by Region (K Units), 2021–2026
Table 18. Global Diabetes Medicines Sales Market Share by Region (2021–2026)
Table 19. Global Diabetes Medicines Sales by Region (K Units), 2027–2032
Table 20. Global Diabetes Medicines Sales Market Share by Region (2027–2032)
Table 21. Global Diabetes Medicines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Diabetes Medicines Revenue Market Share by Region (2021–2026)
Table 23. Global Diabetes Medicines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Diabetes Medicines Revenue Market Share by Region (2027–2032)
Table 25. North America Diabetes Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Diabetes Medicines Sales by Country (K Units), 2021–2026
Table 27. North America Diabetes Medicines Sales by Country (K Units), 2027–2032
Table 28. North America Diabetes Medicines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Diabetes Medicines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Diabetes Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Diabetes Medicines Sales by Country (K Units), 2021–2026
Table 32. Europe Diabetes Medicines Sales by Country (K Units), 2027–2032
Table 33. Europe Diabetes Medicines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Diabetes Medicines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Diabetes Medicines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Diabetes Medicines Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Diabetes Medicines Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Diabetes Medicines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Diabetes Medicines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Diabetes Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Diabetes Medicines Sales by Country (K Units), 2021–2026
Table 42. Latin America Diabetes Medicines Sales by Country (K Units), 2027–2032
Table 43. Latin America Diabetes Medicines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Diabetes Medicines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Diabetes Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Diabetes Medicines Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Diabetes Medicines Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Diabetes Medicines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Diabetes Medicines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Diabetes Medicines Sales (K Units) by Type (2021–2026)
Table 51. Global Diabetes Medicines Sales (K Units) by Type (2027–2032)
Table 52. Global Diabetes Medicines Sales Market Share by Type (2021–2026)
Table 53. Global Diabetes Medicines Sales Market Share by Type (2027–2032)
Table 54. Global Diabetes Medicines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Diabetes Medicines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Diabetes Medicines Revenue Market Share by Type (2021–2026)
Table 57. Global Diabetes Medicines Revenue Market Share by Type (2027–2032)
Table 58. Global Diabetes Medicines Price (US$/Unit) by Type (2021–2026)
Table 59. Global Diabetes Medicines Price (US$/Unit) by Type (2027–2032)
Table 60. Global Diabetes Medicines Sales (K Units) by Application (2021–2026)
Table 61. Global Diabetes Medicines Sales (K Units) by Application (2027–2032)
Table 62. Global Diabetes Medicines Sales Market Share by Application (2021–2026)
Table 63. Global Diabetes Medicines Sales Market Share by Application (2027–2032)
Table 64. Global Diabetes Medicines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Diabetes Medicines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Diabetes Medicines Revenue Market Share by Application (2021–2026)
Table 67. Global Diabetes Medicines Revenue Market Share by Application (2027–2032)
Table 68. Global Diabetes Medicines Price (US$/Unit) by Application (2021–2026)
Table 69. Global Diabetes Medicines Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk Diabetes Medicines Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sanofi Diabetes Medicines Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Eli Lilly Diabetes Medicines Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck Diabetes Medicines Product
Table 89. Merck Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. AstraZeneca Diabetes Medicines Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. bayer Company Information
Table 96. bayer Description and Business Overview
Table 97. bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. bayer Diabetes Medicines Product
Table 99. bayer Recent Developments/Updates
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Boehringer Ingelheim Diabetes Medicines Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Johnson & Johnson Diabetes Medicines Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. Takeda Company Information
Table 111. Takeda Description and Business Overview
Table 112. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Takeda Diabetes Medicines Product
Table 114. Takeda Recent Developments/Updates
Table 115. Tonghua Dongbao Company Information
Table 116. Tonghua Dongbao Description and Business Overview
Table 117. Tonghua Dongbao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Tonghua Dongbao Diabetes Medicines Product
Table 119. Tonghua Dongbao Recent Developments/Updates
Table 120. United Pharmaceuticals Company Information
Table 121. United Pharmaceuticals Description and Business Overview
Table 122. United Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. United Pharmaceuticals Diabetes Medicines Product
Table 124. United Pharmaceuticals Recent Developments/Updates
Table 125. Ganli Pharmaceutical Company Information
Table 126. Ganli Pharmaceutical Description and Business Overview
Table 127. Ganli Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Ganli Pharmaceutical Diabetes Medicines Product
Table 129. Ganli Pharmaceutical Recent Developments/Updates
Table 130. Biocon Company Information
Table 131. Biocon Description and Business Overview
Table 132. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Biocon Diabetes Medicines Product
Table 134. Biocon Recent Developments/Updates
Table 135. Conker Pharmaceuticals Company Information
Table 136. Conker Pharmaceuticals Description and Business Overview
Table 137. Conker Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Conker Pharmaceuticals Diabetes Medicines Product
Table 139. Conker Pharmaceuticals Recent Developments/Updates
Table 140. Jiangsu Wanbang Company Information
Table 141. Jiangsu Wanbang Description and Business Overview
Table 142. Jiangsu Wanbang Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Jiangsu Wanbang Diabetes Medicines Product
Table 144. Jiangsu Wanbang Recent Developments/Updates
Table 145. Geropharm Company Information
Table 146. Geropharm Description and Business Overview
Table 147. Geropharm Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Geropharm Diabetes Medicines Product
Table 149. Geropharm Recent Developments/Updates
Table 150. Wockhardt Company Information
Table 151. Wockhardt Description and Business Overview
Table 152. Wockhardt Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Wockhardt Diabetes Medicines Product
Table 154. Wockhardt Recent Developments/Updates
Table 155. Merck Serono Company Information
Table 156. Merck Serono Description and Business Overview
Table 157. Merck Serono Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Merck Serono Diabetes Medicines Product
Table 159. Merck Serono Recent Developments/Updates
Table 160. Novartis Company Information
Table 161. Novartis Description and Business Overview
Table 162. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Novartis Diabetes Medicines Product
Table 164. Novartis Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Diabetes Medicines Distributors List
Table 168. Diabetes Medicines Customers List
Table 169. Diabetes Medicines Market Trends
Table 170. Diabetes Medicines Market Drivers
Table 171. Diabetes Medicines Market Challenges
Table 172. Diabetes Medicines Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Diabetes Medicines
Figure 2. Global Diabetes Medicines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Diabetes Medicines Market Share by Type: 2025 & 2032
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Diabetes Medicines Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Diabetes Medicines Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Global Diabetes Medicines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Diabetes Medicines Market Size (US$ Million), 2021–2032
Figure 12. Global Diabetes Medicines Sales (K Units), 2021–2032
Figure 13. Global Diabetes Medicines Average Price (US$/Unit), 2021–2032
Figure 14. Diabetes Medicines Report Years Considered
Figure 15. Diabetes Medicines Sales Share by Manufacturers in 2025
Figure 16. Global Diabetes Medicines Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Diabetes Medicines Players: Market Share by Revenue in Diabetes Medicines in 2025
Figure 18. Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Diabetes Medicines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Diabetes Medicines Sales Market Share by Country (2021–2032)
Figure 21. North America Diabetes Medicines Revenue Market Share by Country (2021–2032)
Figure 22. United States Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Diabetes Medicines Sales Market Share by Country (2021–2032)
Figure 25. Europe Diabetes Medicines Revenue Market Share by Country (2021–2032)
Figure 26. Germany Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Diabetes Medicines Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Diabetes Medicines Revenue Market Share by Region (2021–2032)
Figure 33. China Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Diabetes Medicines Sales Market Share by Country (2021–2032)
Figure 41. Latin America Diabetes Medicines Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Diabetes Medicines Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Diabetes Medicines Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Diabetes Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Diabetes Medicines by Type (2021–2032)
Figure 52. Global Revenue Market Share of Diabetes Medicines by Type (2021–2032)
Figure 53. Global Diabetes Medicines Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Diabetes Medicines by Application (2021–2032)
Figure 55. Global Revenue Market Share of Diabetes Medicines by Application (2021–2032)
Figure 56. Global Diabetes Medicines Price (US$/Unit) by Application (2021–2032)
Figure 57. Diabetes Medicines Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
